Evidence map›Paper›PMID 41002148›Full record

ArticleMicrobiology spectrum2025

Oral β-lactam combinations are effective

Maiko Yoshikawa, Tomoyasu Nishimura, Kana Misawa, Rina Shimamura, Kenta Suzuki, Shoko Kashimura, Yuki Igarashi, Yuki Enoki, Kazuaki Taguchi, Naoki Hasegawa and 2 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maiko YoshikawaDivision of Pharmacodynamics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.ORCID 0009-0005-0868-8844
Tomoyasu NishimuraDepartment of Infectious Diseases, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.ORCID 0000-0001-9662-5694
Kana MisawaDivision of Pharmacodynamics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.
Rina ShimamuraDivision of Pharmacodynamics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.
Kenta SuzukiDivision of Pharmacodynamics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.
Shoko KashimuraDepartment of Infectious Diseases, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Yuki IgarashiDivision of Pharmacodynamics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.
Yuki EnokiDivision of Pharmacodynamics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.
Kazuaki TaguchiDivision of Pharmacodynamics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.
Naoki HasegawaDepartment of Infectious Diseases, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Ho NamkoongDepartment of Infectious Diseases, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Kazuaki MatsumotoDivision of Pharmacodynamics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.ORCID 0000-0002-5462-1684

Funding

Japan Science and Technology Agency SPRING JPMJSP2123Japan Society for the Promotion of Science 23K07951the Japanese Society for Chemotherapy 70th Anniversary Research Support Programthe Shionogi Infectious Disease Research Promotion Foundation
6 · The paper itself

Abstract

The global incidence and prevalence of pulmonary disease caused by the

Indexed as

Anti-Bacterial Agentsbeta-LactamsClarithromycinMycobacterium aviumMycobacterium avium ComplexAdministration, OralDrug SynergismHumansMicrobial Sensitivity TestsMycobacterium avium-intracellulare InfectionAnti-Bacterial Agentsbeta-LactamsClarithromycinmacrolide resistanceMycobacterium avium complexnontuberculous mycobacteriatebipenemβ-lactam

Identifiers

PMID41002148
PMCPMC12584685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.